Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

C4 THERAPEUTICS, INC.

(CCCC)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

C4 Therapeutics' : Q2 Loss Narrows, Revenue Grows; Secures Orphan Drug Designation for Multiple Myeloma Drug Candidate

08/12/2021 | 04:48am EDT


ę MT Newswires 2021
All news about C4 THERAPEUTICS, INC.
10/14C4 THERAPEUTICS : SVB Leerink Starts C4 Therapeutics at Outperform with $67 Price Target
MT
10/05INSIDER SELL : C4 Therapeutics
MT
09/30C4 THERAPEUTICS : Stifel Starts C4 Therapeutics at Hold With $45 Price Target
MT
09/24INSIDER SELL : C4 Therapeutics
MT
09/22INSIDER SELL : C4 Therapeutics
MT
09/17INSIDER SELL : C4 Therapeutics
MT
09/15Certain Common Stock of C4 Therapeutics, Inc. are subject to a Lock-Up Agreement Ending..
CI
09/15Certain Stock Options of C4 Therapeutics, Inc. are subject to a Lock-Up Agreement Endin..
CI
09/14INSIDER SELL : C4 Therapeutics
MT
08/12C4 THERAPEUTICS' : Q2 Loss Narrows, Revenue Grows; Secures Orphan Drug Designation for Mul..
MT
More news
Analyst Recommendations on C4 THERAPEUTICS, INC.
More recommendations
Financials (USD)
Sales 2021 31,8 M - -
Net income 2021 -103 M - -
Net cash 2021 378 M - -
P/E ratio 2021 -20,1x
Yield 2021 -
Capitalization 2 176 M 2 176 M -
EV / Sales 2021 56,5x
EV / Sales 2022 61,9x
Nbr of Employees 99
Free-Float 87,1%
Chart C4 THERAPEUTICS, INC.
Duration : Period :
C4 Therapeutics, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends C4 THERAPEUTICS, INC.
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 8
Last Close Price 44,91 $
Average target price 60,00 $
Spread / Average Target 33,6%
EPS Revisions
Managers and Directors
Andrew J. Hirsch President, Chief Executive Officer & Director
Lauren White Treasurer, Chief Financial & Accounting Officer
Marc A. Cohen Executive Chairman
Adam S. Crystal Chief Medical Officer
Stewart Fisher Chief Scientific Officer
Sector and Competitors
1st jan.Capi. (M$)
C4 THERAPEUTICS, INC.35.56%2 176
MODERNA, INC.230.95%139 557
LONZA GROUP AG32.63%60 898
IQVIA HOLDINGS INC.42.93%48 923
SEAGEN INC.1.46%32 330
CELLTRION, INC.-39.00%26 036